Limoride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin-dependent (Type 2) diabetes mellitus (NIDDM) whose hyperglycemia cannot be controlled by diet and exercise alone. Limoride may be used concomitantly with metformin when diet, exercise, and or metformin alone do not result in adequate glycemic control.
Limoride is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycemia cannot be controlled by diet and exercise in conjunction with an oral hypoglycemic agent combined use of glimepiride and insulin may increase the potential for hypoglycemia.